Loratadine (Claritin) is Less Sedating Than Cetirizine (Zyrtec)
Loratadine (Claritin) is the less sedating option and should be your first choice when minimizing sedation is a priority for quality of life and safety. 1
Clear Distinction in Sedation Profiles
The evidence from authoritative guidelines establishes an unambiguous hierarchy among second-generation antihistamines regarding sedation:
- Loratadine does NOT cause sedation at recommended doses (10 mg daily) 1
- Cetirizine DOES cause sedation at recommended doses (10 mg daily), with drowsiness reported in 13.7% of patients versus 6.3% with placebo 1
This distinction is explicitly stated in the 2008 Joint Task Force practice parameters, which categorize loratadine alongside fexofenadine and desloratadine as truly non-sedating, while cetirizine is grouped separately as potentially sedating even at standard doses 1.
Real-World Evidence Supports This Distinction
Post-marketing surveillance data involving over 43,000 patients confirms this difference in clinical practice. Cetirizine had 3.53 times higher odds of causing sedation compared to loratadine (95% CI: 2.07-5.42; P<0.0001) 2. Fexofenadine and loratadine were specifically recommended as more appropriate for people in safety-critical jobs due to their lower sedation risk 2.
Important Caveats
When Loratadine May Cause Sedation:
- Doses exceeding 10 mg daily 1
- Patients with low body mass who may reach elevated mg/kg dosing even at standard doses 1
Cetirizine's Variable Effects:
While cetirizine causes mild drowsiness in approximately 14% of patients, some studies show this occurs without performance impairment 1. However, other studies demonstrate that cetirizine at 10 mg or higher does cause performance impairment 1. This inconsistency makes it less reliable when avoiding sedation is critical.
Clinical Algorithm
For otherwise healthy adults requiring antihistamine therapy:
- First choice: Loratadine 10 mg daily (truly non-sedating at recommended dose)
- If loratadine ineffective: Consider cetirizine 10 mg daily, but counsel patient about 14% risk of drowsiness
- Avoid in safety-critical occupations: Do not use cetirizine for patients who drive professionally, operate heavy machinery, or work in positions requiring high alertness 2
- Never exceed recommended doses of loratadine to avoid inducing sedation 1
FDA Labeling Confirmation
The FDA-approved labeling for Claritin explicitly markets it as "Non-Drowsy" at recommended doses 3, reflecting its established safety profile for daytime use without sedation concerns.